PATENT CLAIM ANALYSIS

Application Number: 15980339
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["514", "017800"]

Abstract:
The present invention relates to the field of molecular biochemistry and medicine, and in particular to ligands comprising modified amino acid residues, targeting the amyloid-β peptide associated with Alzheimer's disease for prevention of aggregation, neurotoxicity and use thereof as drugs for treatment of Alzheimer's disease.

Claim (Index 11):
The compound according to  claim 1 , wherein R2, when being a substituted or non-substituted, saturated or unsaturated alkyl or acyl group, comprises from 6 to 16 carbon atoms.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15326320', '14231715', '15049126', '14231724', '13447127']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7635649706029537
- 35 USC 102 Novelty (BERT): 0.5267193511336732
- Combined Prediction Score: 0.7398804086560257
- Mean Citation Score: 287.711694
- Max Citation Score: 296.7792
- Similarity Product: 190.13199372310643

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test